tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

VIR Stock Latest News

Positive Outlook on Vir Biotechnology’s VIR-5500 Amid Competitive mCRPC Market
RatingsPositive Outlook on Vir Biotechnology’s VIR-5500 Amid Competitive mCRPC Market
1M ago
VIR
Vir Biotechnology Holds 2025 Annual Stockholder Meeting
PremiumCompany Announcements
Vir Biotechnology Holds 2025 Annual Stockholder Meeting
1M ago
8K
VIR
Vir Biotechnology price target lowered to $15 from $110 at H.C. Wainwright
PremiumThe Fly
Vir Biotechnology price target lowered to $15 from $110 at H.C. Wainwright
2M ago
VIR
Vir Biotechnology Presents Promising Phase 2 Hepatitis B Data
PremiumCompany Announcements
Vir Biotechnology Presents Promising Phase 2 Hepatitis B Data
2M ago
8K
VIR
Vir Biotechnology reports data from MARCH Phase 2 clinical study
PremiumThe Fly
Vir Biotechnology reports data from MARCH Phase 2 clinical study
2M ago
VIR
Vir Biotechnology’s Earnings Call: Mixed Sentiment Amid Progress
PremiumCompany AnnouncementsVir Biotechnology’s Earnings Call: Mixed Sentiment Amid Progress
2M ago
VIR
Vir Biotechnology: Strong Financials and Promising Pipeline Justify Buy Rating
Premium
Ratings
Vir Biotechnology: Strong Financials and Promising Pipeline Justify Buy Rating
2M ago
VIR
Vir Biotechnology: Strong Financial Health and Promising Clinical Progress Justify Buy Rating
Premium
Ratings
Vir Biotechnology: Strong Financial Health and Promising Clinical Progress Justify Buy Rating
2M ago
VIR
Vir Biotechnology Reports Q1 2025 Financial Results
PremiumCompany Announcements
Vir Biotechnology Reports Q1 2025 Financial Results
2M ago
VIR
Vir Biotechnology reports Q1 EPS (88c), consensus (84c)
PremiumThe Fly
Vir Biotechnology reports Q1 EPS (88c), consensus (84c)
2M ago
VIR
Vir Biotechnology enrolls first patient in ECLIPSE program
PremiumThe Fly
Vir Biotechnology enrolls first patient in ECLIPSE program
4M ago
VIR
Vir Biotechnology’s Strategic Advancements and Financial Health Justify Buy Rating
PremiumRatings
Vir Biotechnology’s Strategic Advancements and Financial Health Justify Buy Rating
4M ago
VIR
Vir Biotechnology Poised for Growth: Buy Rating Reiterated Amid Clinical and Financial Advancements
PremiumRatingsVir Biotechnology Poised for Growth: Buy Rating Reiterated Amid Clinical and Financial Advancements
4M ago
VIR
Vir Biotechnology price target raised to $31 from $26 at Barclays
Premium
The Fly
Vir Biotechnology price target raised to $31 from $26 at Barclays
4M ago
VIR
Vir Biotechnology’s Transformative Year: Earnings Call Insights
Premium
Company Announcements
Vir Biotechnology’s Transformative Year: Earnings Call Insights
4M ago
VIR
Promising Oncology Developments and Strong Financial Outlook Support Buy Rating for Vir Biotechnology
PremiumRatings
Promising Oncology Developments and Strong Financial Outlook Support Buy Rating for Vir Biotechnology
4M ago
VIR
Vir Biotechnology: Balancing Long-term Potential with Near-term Uncertainty – A Hold Rating Analysis
PremiumRatings
Vir Biotechnology: Balancing Long-term Potential with Near-term Uncertainty – A Hold Rating Analysis
4M ago
VIR
Vir Biotechnology’s Promising Pipeline and Strong Financial Position Justify Buy Rating
PremiumRatings
Vir Biotechnology’s Promising Pipeline and Strong Financial Position Justify Buy Rating
4M ago
VIR
Vir Biotechnology Reports 2024 Financial Results and Strategic Advances
PremiumCompany Announcements
Vir Biotechnology Reports 2024 Financial Results and Strategic Advances
4M ago
VIR
Vir Biotechnology: Strong Financial Position and Promising Pipeline Justify Buy Rating
PremiumRatingsVir Biotechnology: Strong Financial Position and Promising Pipeline Justify Buy Rating
4M ago
VIR
Vir Biotechnology reports Q4 EPS (76c), consensus (87c)
Premium
The Fly
Vir Biotechnology reports Q4 EPS (76c), consensus (87c)
4M ago
VIR
VIR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VIR Earnings this Week: How Will it Perform?
4M ago
VIR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >